Cargando…

Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma

BACKGROUND: Tumor size is a valuable prognostic factor because it is considered a measure of tumor burden. However, it is not always correlated with the tumor burden. This study aimed to identify the prognostic role of pathological tumor proportional size using the proportion of tumor cells on the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Hyun Woo, Kim, Young‐Du, Sim, Sung Bo, Moon, Mi Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108050/ https://www.ncbi.nlm.nih.gov/pubmed/35419984 http://dx.doi.org/10.1111/1759-7714.14427

Ejemplares similares

Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2021)

Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar‐predominant lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2021)

Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2022)

Significance of histologic subtype size as a prognostic indicator in stage IA lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2023)

Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma
por: Deng, Yujie, et al.
Publicado: (2022)

Pathologic subtype-defined prognosis is dependent on both tumor stage and status of oncogenic driver mutations in lung adenocarcinoma
por: Dong, Yu, et al.
Publicado: (2017)

Prognosis of wide wedge resection in patients with stage IA1 and IA2 lung adenocarcinoma with total tumor size including the lepidic component greater than 2 cm: a single center retrospective study
por: Moon, Youngkyu, et al.
Publicado: (2020)

Estimating the cure proportion of stage IA lung adenocarcinoma: a population-based study
por: Huang, Zhixin, et al.
Publicado: (2023)

Prognostic significance of limited resection in pathologic stage I lung adenocarcinoma with spread through air spaces
por: Xu, Kuan, et al.
Publicado: (2023)

The prognosis of stage I non-small cell lung cancer with visceral pleural invasion and whole pleural adhesion after video-assisted thoracoscopic lobectomy: A single center retrospective study
por: Moon, Youngkyu, et al.
Publicado: (2020)

CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma
por: Yu, Dongzhi, et al.
Publicado: (2022)

Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma
por: Sim, Jongmin, et al.
Publicado: (2018)

An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma
por: Xu, Yuan, et al.
Publicado: (2022)

DeepRePath: Identifying the Prognostic Features of Early-Stage Lung Adenocarcinoma Using Multi-Scale Pathology Images and Deep Convolutional Neural Networks
por: Shim, Won Sang, et al.
Publicado: (2021)

A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Lymphatic invasion of micropapillary cancer cells is associated with a poor prognosis of pathological stage IA lung adenocarcinomas
por: HIRANO, HIROSHI, et al.
Publicado: (2014)

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
por: Takahashi, Yusuke, et al.
Publicado: (2018)

New additional scoring formula on the Pathological Features in Stage I Lung Adenocarcinoma Patients: Impact on Survival
por: Zhao, Shilei, et al.
Publicado: (2020)

Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors
por: Wang, Yiyang, et al.
Publicado: (2021)

Oncogenic Alterations in Histologically Negative Lymph Nodes Are Associated with Prognosis of Patients with Stage I Lung Adenocarcinoma
por: Tian, Yiping, et al.
Publicado: (2022)

Development of a prognosis‐prediction model incorporating genetic polymorphism with pathologic stage in stage I non‐small cell lung cancer: A multicenter study
por: Lee, Won Kee, et al.
Publicado: (2017)

The prognostic utility of the histologic subtype of stage I lung adenocarcinoma may be diminished when using only the invasive component to determine tumor size for tumor node metastasis (TNM) staging
por: Sung, Yeoun Eun, et al.
Publicado: (2021)

Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinoma
por: Caso, Raul, et al.
Publicado: (2021)

Heterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients
por: Liu, Chia-Hsin, et al.
Publicado: (2015)

Stage I lung adenocarcinoma: the value of quantitative CT in differentiating pathological subtypes and predicting growth of subsolid nodules
por: Xu, Xianqun, et al.
Publicado: (2017)

Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size
por: Chen, Chunji, et al.
Publicado: (2019)

A systematic review and meta-analysis of the influence of STAS on the long-term prognosis of stage I lung adenocarcinoma
por: Yang, Yanhui, et al.
Publicado: (2021)

Nodal Outcomes of Uniportal versus Multiportal Video-Assisted Thoracoscopic Surgery for Clinical Stage I Lung Cancer
por: Choi, Jung Suk, et al.
Publicado: (2020)

Effect of histological subtype and treatment modalities on T1–2 N0–1 small cell lung cancer: A population‐based study
por: Moon, Seok‐whan, et al.
Publicado: (2019)

The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas
por: Cho, Jaeyoung, et al.
Publicado: (2016)

Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Shang, Shipeng, et al.
Publicado: (2022)

Distinct Prognostic Factors of Ground Glass Opacity and Pure-Solid Lesion in Pathological Stage I Invasive Lung Adenocarcinoma
por: Zhai, Wen Yu, et al.
Publicado: (2022)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Expression and prognosis of inducible T‐cell co‐stimulator and its ligand in Chinese stage I–III lung adenocarcinoma patients
por: Zhan, Xiao‐Kai, et al.
Publicado: (2023)

Genetic and immunologic features of recurrent stage I lung adenocarcinoma
por: Kratz, Johannes R., et al.
Publicado: (2021)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Autonomic nervous infiltration positively correlates with pathological risk grading and poor prognosis in patients with lung adenocarcinoma
por: Shao, Jing‐Xin, et al.
Publicado: (2016)

Prognostic impact of noninvasive areas in resected pathological stage IA lung adenocarcinoma
por: Kinoshita, Fumihiko, et al.
Publicado: (2023)

The prognostic significance of tumor spread through air space in stage I lung adenocarcinoma
por: Huang, Liling, et al.
Publicado: (2022)

Outcomes of patients with different lepidic percentage and tumor size of stage I lung adenocarcinoma
por: Liu, Chia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjf11gau0tu0em9ihl5h4p2g6h